Next-Generation Blood Vessel Assessment System

A system for evaluating blood vessels using wearable devices, machine learning, and nanoscale sensors to provide personalized, real-time monitoring and treatment of vascular diseases.

The original patent disclosed a system for assessing blood vessels, but it relied on invasive instruments and limited data analysis. The new inventive concept addresses these limitations by introducing wearable devices, machine learning algorithms, and nanoscale sensors to provide more accurate, personalized, and real-time assessments of blood vessel health.

The next-generation blood vessel assessment system comprises a wearable device with a sensor for detecting changes in blood flow, a processing unit for generating a personalized 3D model of the vessel, and a machine learning module for predicting stenosis. The system also includes a nanoscale sensor array for detecting biomarkers of vessel damage and a wireless communication module for transmitting the detected biomarkers to a remote server. Additionally, the system incorporates a database of genomic and proteomic data of a patient and a processing unit configured to generate a customized treatment plan based on the data.

The new claims introduce the use of wearable devices, machine learning algorithms, and nanoscale sensors, which are not present in the original patent. These elements provide a significant improvement in accuracy, personalization, and real-time monitoring of blood vessel health, making the new inventive concept novel and non-obvious.

Alternative embodiments of the inventive concept could include the use of different types of sensors, such as optical or acoustic sensors, or the integration of additional data sources, such as electronic health records or medical imaging data. Variations could also include the use of different machine learning algorithms or the development of new biomarkers for vessel damage.

The next-generation blood vessel assessment system has significant commercial potential in the healthcare industry, particularly in the fields of cardiology, vascular surgery, and personalized medicine. The system could be marketed as a diagnostic tool for early detection of vascular diseases, a monitoring system for patients with existing conditions, or a personalized treatment planning platform for healthcare providers.